Abstract
This European Randomized study of Screening for Prostate Cancer trial follow-up reports that repeated screening reduces the risk of dying from prostate cancer for up to 16 yr.
Original language | English |
---|---|
Pages (from-to) | 43-51 |
Journal | European Urology |
Volume | 76 |
Issue number | 1 |
Early online date | 2019 Feb 26 |
DOIs | |
Publication status | Published - 2019 |
Subject classification (UKÄ)
- Cancer and Oncology
- Urology and Nephrology
- Public Health, Global Health, Social Medicine and Epidemiology
Keywords
- Mortality
- Prostate cancer
- Prostate-specific antigen
- Screening